Adcetris
List of products in the National Drug Code with proprietary name adcetris. Brentuximab is used to treat certain types of cancers (Hodgkin's lymphoma, systemic anaplastic large cell lymphoma, peripheral T-cell lymphoma, primary cutaneous anaplastic large cell lymphoma, CD30-expressing mycosis fungoides). It works by slowing or stopping the growth of cancer cells.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
---|---|---|---|---|---|---|
51144-050 | Adcetris | Brentuximab Vedotin | Injection, Powder, Lyophilized, For Solution | Intravenous | Seagen Inc. | Human Prescription Drug |